-13
NPS Score
VS
Prime Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 55
- TOTAL
RATINGS
RxAdvance Claimed Company
- EMPLOYEE
PARTICIPANTS - 9
- TOTAL
RATINGS
Prime Therapeutics vs RxAdvance
Compare Prime Therapeutics versus RxAdvance for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 55 employees and customers of Prime Therapeutics and 9 employees and customers of RxAdvance.
Prime Therapeutics
Prime Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Prime Therapeutics. Their current valuation is $1.76B.
RxAdvance
RxAdvance's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of RxAdvance.
2.9/5
Product Quality
1.9/5
2.7/5
Pricing
2/5
2.6/5
Customer Service
2/5
| 37% | Promoters |
|---|---|
| 13% | Passive |
| 50% | Detractors |
Net Promoter Score
Winner by 39
-52
NPS Score
| 24% | Promoters |
|---|---|
| 0% | Passive |
| 76% | Detractors |
See how Prime Therapeutics compares to its competitors
See how RxAdvance compares to its competitors
Working at Prime Therapeutics vs Working at RxAdvance
70 / 100
CEO Rating
Winner by 11%
59 / 100
CEO Rating
Prime Therapeutics
Prime Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
RxAdvance
Employees at RxAdvance rate their CEO, Ravi Ika, 59/100. This score is 11% lower than the scores of Prime Therapeutics' CEO, Jim DuCharme.